Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
39 hedge funds and large institutions have $6.68M invested in Checkpoint Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 6 reducing their positions, and 4 closing their positions.
183% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 6
138% more call options, than puts
Call options by funds: $107K | Put options by funds: $45K
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
15% more funds holding
Funds holding: 34 → 39 (+5)
1.14% more ownership
Funds ownership: 17.66% → 18.8% (+1.1%)
2% more capital invested
Capital invested by funds: $6.51M → $6.68M (+$162K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.48M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$466K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$215K |
| 4 |
PAS
Park Avenue Securities
New York
|
+$136K |
| 5 |
PAM
PVG Asset Management
Golden,
Colorado
|
+$114K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AWM
Apollon Wealth Management
Mount Pleasant,
South Carolina
|
-$69.4K |
| 2 |
JF
Jump Financial
Chicago,
Illinois
|
-$40.8K |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$35.8K |
| 4 |
BlackRock
New York
|
-$30.6K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.6K |
CKPT Hedge Fund Activity: Q3 2023 in Review
39 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q3 2023, worth a combined $6.68M — up 2.5% from $6.51M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CKPT positions and 4 closed out — a net gain of 5 holders — while 17 added to existing stakes and 6 trimmed.
The largest buyer was Armistice Capital, adding an estimated $1.48M. The largest seller was Apollon Wealth Management, cutting an estimated $69.4K.
- 39 institutional investors held Checkpoint Therapeutics (CKPT) as of Q3 2023, up from 34 in Q2 2023.
- Funds reported $6.68M of Checkpoint Therapeutics stock for Q3 2023, up 2.5% quarter-over-quarter.
- 9 funds opened new Checkpoint Therapeutics positions in Q3 2023 and 4 closed out, a net change of +5 holders.
- The largest Checkpoint Therapeutics buyer in Q3 2023 was Armistice Capital, an estimated $1.48M added.
- The largest Checkpoint Therapeutics seller in Q3 2023 was Apollon Wealth Management, an estimated $69.4K sold.
Based on aggregated 13F filings for Q3 2023.